$32.17
-0.38 (-1.17%)
Performance
1D
—
1W
—
1M
—
3M
-13.47%
6M
+25.81%
1Y
+14.97%
YTD
-9.18%
Open$32.38
Previous Close$32.55
Day High$32.76
Day Low$31.71
52W High$43.15
52W Low$18.92
Volume—
Avg Volume2.49M
Market Cap3.93B
P/E Ratio—
EPS$-3.18
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.83
Below
SMA 200
$31.34
Above
RSI (14)
52.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+112.0% upside
Current
$32.17
$32.17
Target
$68.21
$68.21
$46.84
$68.21 avg
$80.11
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.82B | 1.78B | 1.68B |
| Net Income | 202.06M | 220.26M | 147.13M |
| Profit Margin | 11.1% | 12.3% | 8.7% |
| EBITDA | 246.26M | 251.94M | 230.42M |
| Free Cash Flow | 210.43M | 219.41M | 153.78M |
| Rev Growth | +17.6% | -0.7% | +11.4% |
| Debt/Equity | 0.22 | 0.23 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |